InnovoTEX Inc.
Amendment
CIK: 0001971887·Biotechnology·DELAWARE·Filed: Aug 18, 2026
Total Offering
$4,000,000
Amount Sold
$2,720,484
Investors
21
First Sale
Nov 19, 2024
Offering Details
- Type
- Equity, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Year Incorporated
- 2022
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Krystle Karoscik | |
| Jonathan Arambula | |
| Jonathan Sessler | |
| James Hussey |
Company
SEC Filing
0001971887-26-000005
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free